El GLP-1 tiene capacidad para reducir el apetito, mejorar la sensibilidad a la insulina y favorecer la prdida de peso, y por ello se ha convertido en el centro de atencin de redes sociales y blogs especializados del sector del fitness
You might have expected the researchers who studied GLP-1 drugs to measure whether people actually got weaker
Retrieved 2010-08-30
Understanding your peptide-pathway genetics reduces trial-and-error dosing, minimizes side effects, and identifies patients who may benefit from alternative weight loss strategies if standard GLP-1 therapy carries elevated risk
Research suggests MOTS-c may support metabolism by influencing glucose handling, insulin sensitivity, and how cells use fuel
The tolerability of GLP-1 drugs can also pose a challenge, as gastrointestinal issues like nausea, vomiting, diarrhea and constipation can occur from taking them